The Ebb and Flow of Lymphatic Valve Formation  by Udan, Ryan S. & Dickinson, Mary E.
Developmental Cell
PreviewsThe Ebb and Flow of Lymphatic Valve FormationRyan S. Udan1 and Mary E. Dickinson1,*
1Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA
*Correspondence: mdickins@bcm.edu
DOI 10.1016/j.devcel.2012.01.022
Recently, substantial advances have been made in understanding the formation and remodeling of the
lymphatic vasculature. In this issue, Sabine et al. (2012) further define the mechanisms of lymphatic valve
formation and implicate oscillatory shear stress in regulating themolecular events that control valve morpho-
genesis.The vascular system is comprised of both
blood and lymphatic vessels. The latter
form a highly specialized system required
for maintaining the balance of interstitial
fluid in tissues, for immune system sur-
veillance, and for lipid and vitamin ab-
sorption. Like veins in the blood system,
lymphatic vessels contain intraluminal
valves to regulate the flow of lymph
through the body, returning it to the blood
stream via direct connections at lympho-
venous junctions. New work from Sabine
et al. (2012) examines the mechanisms
that regulate the formation of lymphatic
valves.
Previous studies have shed light on
the specification and remodeling of the
lymphatic vasculature (Oliver and Srini-
vasan, 2010). Lymphatic vessels begin
to form shortly after blood vessels
when lymphatic endothelial cells (LECs),
marked by the expression of Prox1 and
LYVE-1, are specified within the cardinal
vein (beginning at E9.5 in the mouse
embryo). Vegf-c, emanating from meso-
dermal cells near the cardinal vein, then
induces the LECs expressing Prox1 to
migrate and form lymph sacs that sub-
sequently become the capillary plexus.
This plexus is further remodeled into the
network of lymph capillaries, precollect-
ing vessels, and collecting vessels of the
mature lymph system in a process that
involves the transcription factor Foxc2.
Valves that regulate lymph flow form
when specified LECs extend into the
lumen to make leaflets that mature into
valves. Several factors are known to regu-
late valve formation, including Foxc2,
NFATc (another transcription factor), in-
tegrin alpha 9, and fibronectin-EIIIA. More
recently, Kanady et al. (2011) have shown
that two gap junction proteins, Connexin
(Cxn) 37 and 43, are also required for
normal valve development. The expres-242 Developmental Cell 22, February 14, 201sion of these two proteins depends on
Foxc2. These studies have revealed
a number of key regulators of valve forma-
tion but did not address signaling up-
stream of Foxc2 or the mechanisms
specify valve-forming cells from LECs.
In this issue, Sabine et al. (2012) identify
some of the early steps in lymphatic valve
formation. First, they carefully establish
the temporal sequence of cellular events
leading to luminal valve formation in col-
lecting vessels. Utilizing both mouse
genetics and in vitro cellular models,
they establish a hierarchy of transcription
factors and cell-cell signaling molecules
that regulate specific stages of valve
development. Combined with previous
studies, the data delineate four dis-
tinct phases of lymph valve development:
initiation, condensation, elongation, and
maturation.
Initiation of valve formation begins
with the establishment of a region of
lymphatic-valve-forming cells clustered
on one side of the collecting vessel. These
cells are defined by the expression of high
levels of Prox1 and Foxc2, creating a
clear boundary with the neighboring lym-
phangion cells (the segment between
valves) that express reduced levels of
thesemarkers. Establishing this boundary
of expression appears to involve calci-
neurin/NFAT signaling given that muta-
tions in the calcineurin regulatory subunit,
Cnb1, result in a poor demarcation of this
boundary and a failure of valve formation
to progress to subsequent stages.
During condensation valve-forming
cells adopt a cuboidal shape, leading to
the formation of ring-like constrictions of
the vessel. This step requires connexin
37 (Cx37), indicating a role for gap junc-
tion formation. Furthermore, Foxc2 is
required for high Cx37 expression, indi-
cating that Cx37 is downstream of Foxc2.2 ª2012 Elsevier Inc.Elongation is marked by the extension
of valve-forming cells into the lumen to
form valve leaflets. This process corre-
lates with an upregulation in extracel-
lular matrix (ECM) components (laminin
alpha5, collagen IV, and fibronectin [FN-
EIIIA]) as well as increased expression of
integrin alpha9.
Finally, at the maturation stage the two
valve leaflets mature and a thick ECM
core forms. ECM deposition and the
stability of elongating and mature valves
require continued calcineurin signaling,
given that Cnb1 loss at postnatal stages
results in reduced ECMand in valve leaflet
regression. Thus, these data support a
model in which Cnb1 is required for local-
ized Prox1 and Foxc2 upregulation, which
in turn activates Cx37 expression, which
is necessary for the coalescence of cells
within the primordial valve region.
While these data further define the
pathway that leads to valve formation,
an important remaining question is what
sets this cascade of events in motion. It
is known that lymph valves often form at
lymphatic vessel branch points, where
lymph flow may be disturbed (Kampme-
ier, 1928). The authors therefore test
whether oscillatory fluid motion may play
a role in valve formation. Using in vitro
flow experiments, Sabine et al. (2012)
show that oscillatory but not laminar
flow introduced to LECs in vitro induces
NFATc and Cx37 expression in a Foxc2-
and Prox1-dependent manner, similar to
the upregulation that precedes valve in-
duction in vivo. Furthermore, Sabine
et al. (2012) also show that nondirectional
fluid motion occurs in lymphatic vessels
in the embryo at the time that valves are
first induced and that eNOS expression,
which is upregulated by oscillatory flow
in vitro, increases prior to the clustering
of valve-forming cells (the initiation stage
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sels cultured ex vivo, in the absence of
fluid flow, lose the patterned expression
of Prox1 and Foxc2 and fail to assemble
valves properly. Taken together, these
data support the hypothesis that valve
formation is initiated by oscillatory shear
stress.
In vivo testing of this hypothesis awaits
future studies. In the blood system, formal
evidence that hemodynamic force can
regulate blood vessel remodeling and
heart valve formation in vivo has been es-
tablished by altering blood viscosity and
manipulating heart function (Lucitti et al.,
2007; Vermot et al., 2009). However, there
is no simple means to alter lymph flow
in vivo because lymph flow is not regu-
lated by a central pump. Instead, lymph
propulsion is controlled via contractile
forces generated by smooth muscle cells
(Zawieja, 2009), and thus it may be
possible to interfere with lymph flow by
targeting the smooth muscle cell layers
that form around collecting vessels.
A more complete understanding of the
molecular mechanisms of force-sensing
will help to determine whether mecha-
nisms that govern blood vessel and heart
valve development are similar to those
that contribute to lymph valve formation.
Understanding how these systems oper-
ate during development is complicated
by the fact that flow often regulates mole-cules that also have flow-independent
roles. For instance, while it is known that
the initial specification of arterial-venous
identity is initiated prior to blood flow,
alterations in blood flow can clearly re-
program endothelial cells by influencing
these pathways (le Noble et al., 2004).
Similarly, as Sabine et al. (2012) show,
Prox1 is required both early, for the spec-
ification of LECs, and then later, for the
formation of valves and for flow-induced
changes in cell shape. Understanding
how multiple triggers to these pathways
are balanced is a challenge for future
work.
The mechanisms outlined here for
lymph valves may be very similar to those
employed in the formation of venous
valves (Bazigou et al., 2011). Interestingly,
Sabine et al. (2012) also show that Foxc2
and Cx37 are also expressed in arteries,
which normally do not form valves, but
they report that arterial Cx37 expression
is not reduced in Foxc2 null embryos as
it is in the lymphatic vessels. These data
indicate that Cx37 is regulated differently
in arteries than in lymphatics and the
two vessel systems have very different
flow properties will be interesting to deter-
mine whether such differences relate to
differences in fluid flow between these
systems or whether flow-independent
events govern pathway biases in different
cell types. Future studies will no doubtDevelopmental Cell 22,rely heavily on biosensors that can show
when and where forces are generated
and how specific downstream signaling
pathways are activated (Conway and
Schwartz, 2012).REFERENCES
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